Victoria Socha

DocwireNews

Amy Larkin, PharmD, and Donald Blatherwick at Medscape, New York, New York, conducted an analysis to examine whether virtual patient simulation (VPS)-based continuing medical education (CME) would&nbsp; improve the performance of nephrologists in diagnosing and managing patients with hyperkalemia. Results were reported during a poster session at the NKF 2022 Spring Clinical Meetings in a poster titled Effective Online Virtual Patient Simulation Can Improve Diagnosis and Management of CKD and Chronic Hyperkalemia by Nephrologists.The <a href="https://www.docwirenews.com/nephtimes/cme-chronic-hyperkalemia-ckd/">intervention</a> consisted of a patient presenting at two different time points in a VPS platform that allows learners to order laboratory tests, make diagnoses, and prescribe treatments in a manner matching the scope and depth of actual practice.Following each decision, tailored clinical guidance (CG) based on current evidence and expert recommendations was provided. Learners were then provided an opportunity to modify their decisions. Following completion of the clinical guidance portion of the intervention, decisions were collected and compared with each user&rsquo;s baseline decisions. P values were determined using a McNemar&rsquo;s test. The activity was posted October 30, 2020; initial data were collected through March 10, 2021.A total of 86 nephrologists completed the activity (all decisions within at least one case) and were included in the analysis of results. Following CG, there were significant improvements.During the simulated initial visit, there were seven decisions of interest: (1) diagnose CKD stage 3b; (2) diagnose hyperkalemia; (3) initiate a potassium binder; (4) initiate loop diuretic; (5) discontinue oral naproxen; (6) order patient education; and (7) order nutritional counseling.Improvements in the seven decisions following CG were: (1) 34% absolute improvement (8% pre-CG vs 42% post-CG; P&lt;.01); (2) 29% absolute improvement (8% pre-CG vs 37% post-CG; P&lt;.01); (3) 36% absolute improvement (22% pre-CG vs 58% post-CG; P&lt;.01); (4) 57% absolute improvement (5% pre-CG vs 62% post-CG; P&lt;.01); (5) 10% absolute improvement (85% pre-CG vs 95% post-CG; P&lt;.01); (6) 12% absolute improvement (50% pre-CG vs 62% post-CG; P&lt;.01; and (7) 15% absolute improvement (50% pre-CG vs 65% post-CG; P&lt;.01), respectively.During the simulated follow-up visit, there were five decisions of interest: (1) diagnose chronic hyperkalemia; (2) continue potassium binder; (3) continue loop diuretic; (4) order patient education; and (5) order nutritional counseling. Post-CG, improvements were: (1) 36% absolute improvement (4% pre-CG vs 40% post-CG; P&lt;.01); (2) 9% absolute improvement (89% pre-CG vs 98% post-CG; P&lt;.05); (3) 11% absolute improvement (87% pre-CG vs 98% post-CG; P&lt;.05); (4) 13% absolute improvement (47% pre-CG vs 60% post-CG; P&lt;.01; and (5) 17% absolute improvement (36% pre-CG vs 53% post-CG; P&lt;.01), respectively.The researchers said, &ldquo;VPS that immerses and engages specialists in an authentic and practical learning experience can improve evidence-based clinical decisions related to patient identification and management of hyperkalemia.&rdquo;Source: Larkin A, Blatherwick D. Effective online virtual patient simulation can improve diagnosis and management of CKD and chronic hyperkalemia by nephrologists. Abstract of a poster (poster 296) presented at the National Kidney Foundation 2022 Spring Clinical Meetings, Boston, Massachusetts, April 6-10, 2022.

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Online CME Improves Diagnosis and Management of Hyperkalemia in CKD

Chronic Kidney Disease

Amy Larkin, PharmD, and Donald Blatherwick at Medscape, New York, New York, conducted an analysis to examine whether virtual patient simulation (VPS)-based continuing medical ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe